WR

White Rose Technology Seedcorn Fund

Europe, Glasgow City, United Kingdom, Glasgow

Description

The White Rose Technology Seedcorn Fund is an early stage seedcorn fund, which invests in exciting new technology emerging from the

Investor Profile

White Rose Technology Seedcorn Fund has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (83%)
  • Seed (17%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Manufacturing
  • Medical
  • Pharmaceutical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does White Rose Technology Seedcorn Fund frequently co-invest with?

YFM Equity Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Finance Yorkshire
Europe, Gloucestershire, United Kingdom, Barnsley
Co-Investments: 1
Aquarius Equity Partners
Europe, Manchester, United Kingdom, Manchester
Co-Investments: 1
PV
Europe, England, United Kingdom, London
Co-Investments: 1
South Yorkshire Investment Fund
Europe, Barnsley, United Kingdom, Dodworth
Co-Investments: 1
Innogenetics
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 1
VF
Europe, Nottinghamshire, United Kingdom, Normanton On Trent
Co-Investments: 1
IP Group
Europe, England, United Kingdom, London
Co-Investments: 1
Yorkshire Cancer Research
Europe, North Yorkshire, United Kingdom, Harrogate
Co-Investments: 3

What are some of recent deals done by White Rose Technology Seedcorn Fund?

Cizzle Biotech Ltd.

York, York, United Kingdom

Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker.

BiotechnologyHealth Care
Series UnknownMar 12, 2012
Amount Raised: $853,377
Cizzle Biotech Ltd.

York, York, United Kingdom

Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker.

BiotechnologyHealth Care
Series UnknownJan 1, 2008
Pro-Cure Therapeutics

York, York, United Kingdom

Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells.

BiotechnologyHealth DiagnosticsMedicalPharmaceutical
Series UnknownNov 8, 2007
Amount Raised: $1,159,530
CellTran

Sheffield, Sheffield, United Kingdom

CellTran is a biotechnology company engaged in the development of cell therapy products for the wound management industry.

BiotechnologyHealth CareManufacturing
Series UnknownAug 21, 2007
Amount Raised: $1,982,447
Tissue Regenix

York, York, United Kingdom

Tissue Regenix commercializes innovative technologies in regenerative medicine.

Health CareHealth DiagnosticsMedical Device
Series UnknownJan 2, 2007
Amount Raised: $1,349,966
Cizzle Biotech Ltd.

York, York, United Kingdom

Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker.

BiotechnologyHealth Care
SeedJan 1, 2006